1,041 material Form 8-K filings that 824 companies we cover made with the SEC in November 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Hawaiian Electric Industries reported third quarter 2025 net income of $31 million, or $0.18 per diluted share, compared with a loss from continuing operations of $123 million, or $1.08 per share, in the same quarter of 2024. Total revenues fell to $790.6 million from $833.2 million, and core earnings per share declined to $0.19 from $0.29, so shareholders see a mixed picture of higher reported profit but lower revenue and core results.
Third quarter net income was $31 million, or $0.18 per diluted share, versus a loss from continuing operations of $123 million, or $1.08 per share, a year earlier.
Core income from continuing operations was $33 million, or $0.19 per share, compared with $33 million, or $0.29 per share, in the third quarter of 2024.
Total revenues were $790.6 million, down from $833.2 million a year earlier.
In September, the credit facility was expanded to $600 million from $375 million, and about $500 million of Hawaiian Electric debt was issued.
Viasat reported fiscal second-quarter 2026 results, with revenue of $1.1 billion up 2% from a year earlier and a net loss of $61 million, compared with $138 million a year earlier. The company reiterated most of its fiscal 2026 outlook, including low single-digit revenue growth and flattish Adjusted EBITDA, so shareholders see improved headline results with guidance held steady rather than changed.
Q2 FY2026 revenue was $1.1 billion, up 2% year over year, led by 3% growth in Defense and Advanced Technologies.
Net loss attributable to Viasat was $61 million, versus $138 million in Q2 FY2025.
Adjusted EBITDA was $385 million, up 3% year over year; free cash flow was $69 million.
Fiscal 2026 guidance was kept for low single-digit revenue growth and flattish Adjusted EBITDA; net debt was $5.5 billion at quarter end.
National HealthCare Corporation reported third quarter 2025 results, with net operating revenues up 12.5% year over year to $382.7 million, driven by an 8.7% increase in same-facility revenues and the August 2024 acquisition of White Oak Management. GAAP net income attributable to NHC fell to $39.2 million from $42.8 million, while adjusted (non-GAAP) net income rose 24.3% to $24.7 million, so shareholders see higher revenue and adjusted earnings alongside lower reported GAAP profit.
Net operating revenues were $382.7 million for the quarter ended September 30, 2025, versus $340.2 million a year earlier.
GAAP diluted EPS was $2.50, down from $2.73; adjusted diluted EPS was $1.58, up from $1.27.
GAAP net income attributable to NHC was $39.2 million, versus $42.8 million; the adjusted figure excludes unrealized gains on marketable equity securities.
Dividends declared were $0.64 per common share, up from $0.61.
Franklin Resources reported preliminary fourth-quarter results for the period ended September 30, 2025, with net income attributable to the company of $117.6 million, or $0.21 per diluted share, compared with a net loss of $84.7 million a year earlier. Operating revenues rose 6% year over year, while operating income fell from the prior quarter after a $202.2 million impairment of intangible assets, and the company reported $11.9 billion of long-term net outflows. For shareholders, the quarter shows a return to profit, while fiscal year adjusted diluted earnings per share declined to $2.22 from $2.39.
Q4 operating revenues were $2,343.7 million, up 6% from $2,211.2 million a year earlier and 14% from $2,064.0 million in the prior quarter.
Q4 net income attributable to Franklin Resources was $117.6 million, or $0.21 per diluted share, versus a net loss of $84.7 million, or $0.19 per share, in Q4 fiscal 2024.
Q4 operating income was $85.4 million, down 45% from $154.1 million in the prior quarter, after a $202.2 million impairment of intangible assets.
Q4 adjusted diluted earnings per share were $0.67, up from $0.49 in the prior quarter and $0.59 a year earlier; fiscal year adjusted net income was $1,195.8 million, down 6%.
Koppers reported third quarter 2025 net sales of $485.3 million, down 12.4% from $554.3 million a year earlier, and adjusted EBITDA of $70.9 million, down from $77.4 million. GAAP diluted EPS rose to $1.17 from $1.09, but adjusted EPS fell to $1.21 from $1.37. The company cut its 2025 sales forecast to about $1.9 billion from $1.9 billion to $2.0 billion and set adjusted EBITDA guidance of $255 million to $260 million and adjusted EPS of $4.00 to $4.15.
Q3 2025 net sales were $485.3 million vs. $554.3 million, and adjusted EBITDA was $70.9 million vs. $77.4 million.
GAAP diluted EPS was $1.17 vs. $1.09; adjusted EPS was $1.21 vs. $1.37.
2025 sales forecast revised to about $1.9 billion, from $1.9 billion to $2.0 billion previously.
2025 adjusted EBITDA guidance is $255 million to $260 million and adjusted EPS guidance is $4.00 to $4.15; the CEO expects adjusted EPS in the lower half of the previous range.
American Axle & Manufacturing (AAM, NYSE: AXL) reported third-quarter 2025 sales of $1.51 billion, up slightly from $1.50 billion a year earlier, while net income fell to $9.2 million from $10.0 million. Adjusted EBITDA rose to $194.7 million from $174.4 million, and the company narrowed its full-year 2025 sales, Adjusted EBITDA and Adjusted free cash flow targets. The filing names American Axle & Manufacturing Holdings, Inc. as the registrant, although the request identified the filer as Dauch Corp (DCH).
Q3 2025 net income was $9.2 million, or $0.07 per diluted share, versus $10.0 million, or $0.08, in Q3 2024.
Q3 2025 Adjusted EBITDA was $194.7 million, or 12.9% of sales, versus $174.4 million, or 11.6%, a year earlier.
Full-year 2025 Adjusted EBITDA target is $710 million to $745 million, versus $695 million to $745 million previously.
Full-year 2025 sales target is $5.8 billion to $5.9 billion, versus $5.75 billion to $5.95 billion previously.
Sunstone Hotel Investors reported third-quarter 2025 results with net income of $1.3 million, down 59.3% from $3.2 million a year earlier, and Adjusted EBITDA re of $50.1 million, down 6.6%. Total Portfolio RevPAR rose 2.0% to $216.12, but profit measures declined, and the company maintained its full-year 2025 outlook.
Q3 net income was $1.3 million versus $3.2 million in Q3 2024; loss per diluted share attributable to common stockholders was $(0.02).
Total Portfolio RevPAR rose 2.0% to $216.12 with occupancy of 70.3% and average daily rate of $307.43.
Adjusted FFO per diluted share was $0.17, down 5.6% from $0.18; full-year 2025 guidance was maintained, including Adjusted FFO per diluted share of $0.80 to $0.87.
A new $1.35 billion credit agreement addresses all debt maturities through 2028 and lowers borrowing cost, according to the company.
TDS reported third-quarter 2025 operating revenues from continuing operations of $308.5 million, down from $327.5 million a year earlier, while diluted earnings per share from continuing operations rose to $0.33 from a loss of $0.88. The company also authorized a new $500 million share repurchase program and named Anthony Carlson president and CEO of Array effective November 16, 2025.
Q3 2025 operating revenues from continuing operations: $308.5 million, versus $327.5 million in Q3 2024
Diluted EPS from continuing operations: $0.33, versus $(0.88) a year earlier
Net loss attributable to TDS common shareholders: $(99.1) million for the quarter, per the filing's income statement, including $(139.3) million from discontinued operations
New $500 million share repurchase program, with no expiration; TDS repurchased 1,077,564 shares for $40.7 million in Q3
DoubleVerify reported third-quarter 2025 revenue of $188.6 million, up 11% from a year earlier, with adjusted EBITDA of $65.9 million at a 35% margin. Net income fell to $10.2 million from $18.2 million, and diluted EPS was $0.06 versus $0.10. The company raised its full-year 2025 adjusted EBITDA margin guidance to approximately 33% from 32% and expects full-year revenue growth of approximately 14%.
Q3 2025 revenue of $188.6 million, up 11%; activation revenue $106.7 million, up 10%
Net income of $10.2 million versus $18.2 million in Q3 2024; diluted EPS $0.06 versus $0.10
Full-year 2025 adjusted EBITDA margin guidance raised to approximately 33% from 32%
Q4 2025 revenue guidance of $207 million to $211 million; adjusted EBITDA of $77 million to $81 million
Sylvamo reported third-quarter 2025 net income of $57 million ($1.41 per diluted share) on net sales of $846 million, up from $15 million in the second quarter but down from $95 million in the third quarter of 2024. The company expects fourth-quarter 2025 adjusted EBITDA of $115 million to $130 million, below the $151 million it reported for the third quarter, so shareholders face a mixed picture of sequential improvement and a weaker year-over-year and outlook trend.
Q3 2025 net sales of $846 million, up from $794 million in Q2 2025 but down from $965 million in Q3 2024.
Net income of $57 million ($1.41 per diluted share), compared with $95 million ($2.27 per diluted share) in Q3 2024.
Adjusted EBITDA of $151 million (18% margin), versus $82 million in Q2 2025 and $193 million in Q3 2024.
Q4 2025 adjusted EBITDA outlook of $115 million to $130 million.
Essent Group reported third-quarter 2025 net income of $164.2 million, or $1.67 per diluted share, down from $176.2 million, or $1.65 per diluted share, a year earlier. Total revenues were $311.8 million, compared with $316.6 million in the prior-year quarter, and the Board declared a $0.31 quarterly dividend and approved a new $500 million share repurchase authorization.
Net income was $164.2 million versus $176.2 million a year earlier, while diluted EPS rose to $1.67 from $1.65.
Total revenues were $311.8 million versus $316.6 million in Q3 2024.
Quarterly dividend of $0.31 per share is payable December 10, 2025, to holders of record on December 1, 2025.
Through October 31, the company had repurchased 8.7 million shares for $501 million; a $500 million authorization runs through year-end 2027.
Wendy's reported unaudited third-quarter 2025 results for the quarter ended September 28, 2025, with total revenues down 3.0% and net income down 11.8%. Adjusted EBITDA rose 2.1% to $138.0 million, and the company reaffirmed its 2025 adjusted EBITDA and adjusted EPS outlook while raising its free cash flow outlook, but shareholders saw lower revenue, profit and earnings per share in the quarter.
Total revenues were $549.5 million, down 3.0% from $566.7 million a year earlier; adjusted EPS was $0.24, down 4.0%.
Net income was $44.3 million, down 11.8%; diluted EPS was $0.23 versus $0.25.
Reaffirmed 2025 adjusted EBITDA of $505 to $525 million and adjusted EPS of $0.82 to $0.89; raised free cash flow outlook to $195 to $210 million from $160 to $175 million.
On November 5, 2025, the Board amended the By-Laws, including stockholder written consent record date procedures and removing the stockholder list requirement for meetings.
Fluor reported third quarter 2025 revenue of $3.4 billion, down 18% from a year earlier, and a GAAP net loss attributable to Fluor of $697 million. The loss reflects a $653 million charge for the Santos ruling and a $401 million reduction tied to NuScale's share price, while adjusted EPS rose to $0.68 and the company raised its 2025 adjusted EPS and adjusted EBITDA guidance.
Q3 revenue was $3.4 billion, down 18% year over year, reflecting a $653 million reduction for the Santos ruling
Adjusted EPS was $0.68, up 33% year over year; GAAP EPS was ($4.30)
2025 adjusted EBITDA guidance raised to $510 million to $540 million from $475 million to $525 million
Q3 share repurchases were $70 million, with an additional $800 million targeted through February
Constellation reported third quarter 2025 results on November 7, 2025, with adjusted operating earnings of $3.04 per share, up from $2.74 a year earlier, while GAAP net income fell to $2.97 per share from $3.82. The company narrowed its full-year 2025 adjusted operating earnings guidance to $9.05 to $9.45 per share, and the results are reported as the company prepares to close its proposed Calpine transaction.
Q3 2025 operating revenues were $6.57 billion, compared with $6.55 billion in Q3 2024.
GAAP net income attributable to common shareholders was $930 million, or $2.97 per diluted share, versus $1.2 billion, or $3.82 per share, a year earlier.
Full-year 2025 adjusted operating earnings guidance was narrowed to $9.05 to $9.45 per share.
In September 2025, a settlement with Maryland regulators cleared a water quality certification for re-licensing the Conowingo Dam hydroelectric facility.
ANI Pharmaceuticals reported third-quarter 2025 net revenues of $227.8 million, up 53.6% from a year earlier, and GAAP net income attributable to common shareholders of $26.3 million, or $1.13 per diluted share, compared with a loss of $1.27 per share in the prior-year quarter. The company raised its full-year 2025 total net revenue guidance to $854 million to $873 million and its adjusted non-GAAP EBITDA guidance to $221 million to $228 million, which points to higher expected results for shareholders.
Q3 2025 net revenues were $227.8 million, up 53.6% from $148.3 million in Q3 2024.
Cortrophin Gel net revenues were $101.9 million, up 93.8% year over year.
GAAP diluted EPS was $1.13 versus a loss of $1.27 a year earlier; adjusted non-GAAP diluted EPS was $2.04.
2025 total net revenue guidance was raised to $854 million to $873 million, from $818 million to $843 million; ILUVIEN net revenue was $16.6 million in the quarter, which the company said was pressured by reduced Medicare access.
KKR reported third quarter 2025 results on November 7, 2025. GAAP net income attributable to KKR common stockholders was $859.9 million, or $0.90 per diluted share, compared with $600.6 million, or $0.64, a year earlier, while total revenues rose to $5.53 billion from $4.79 billion. Fee Related Earnings reached a record $1.0 billion, and new capital raised was $43 billion.
GAAP net income to KKR common stockholders of $859.9 million, or $0.90 diluted per share, versus $600.6 million, or $0.64, in 3Q'24
Total revenues of $5.53 billion, up from $4.79 billion a year earlier
Fee Related Earnings of $1.0 billion ($1.15 per adjusted share), a record for KKR and up 3% year over year
Regular dividend of $0.185 per share declared for the quarter; assets under management of $723 billion, up 16% year over year
CNH Industrial reported third-quarter 2025 net income of $67 million and diluted EPS of $0.06, down from $310 million and $0.24 a year earlier, on consolidated revenues of $4.40 billion, down 5%. The company lowered its 2025 adjusted diluted EPS outlook to $0.44 to $0.50, citing tariff headwinds and an unfavorable geographic sales mix, while raising its net sales guidance.
Q3 2025 net income was $67 million versus $310 million in Q3 2024; diluted EPS was $0.06 versus $0.24.
Adjusted EBIT of Industrial Activities fell 69% to $104 million; Agriculture adjusted EBIT margin was 4.6%, down from 10.2%.
Updated 2025 outlook: adjusted diluted EPS of $0.44 to $0.50; Agriculture net sales down 11% to 13% year over year.
Free cash flow of Industrial Activities was negative $188 million in Q3 2025; 2025 full-year guidance is $200 million to $500 million.
MarketAxess reported third-quarter 2025 results on November 7, 2025. Revenue rose 1% to $208.8 million, but net income fell 4% to $68.3 million and diluted EPS fell 3% to $1.84, as expenses rose 3% and U.S. credit commission revenue declined 7%. The company also declared a quarterly dividend of $0.76 per share.
Total revenues of $208.8 million rose 1% year over year; total commission revenue of $180.2 million was flat.
Diluted EPS of $1.84 fell 3%, and GAAP net income of $68.3 million fell 4%.
Total expenses rose 3% to $123.2 million, and U.S. credit commission revenue fell 7%, which management attributed to lower volatility, tighter credit spreads and September issuance.
Quarterly dividend of $0.76 per share is payable December 3, 2025, to holders of record on November 19, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.